Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Immunopathol Pharmacol ; 26(1): 27-36, 2013.
Article in English | MEDLINE | ID: mdl-23527706

ABSTRACT

IL-36 is another family member of IL-1 and induces the production of proinflammatory cytokines and activates MAPK and NFkB pathways. IL-36 is a common mediator of innate and adaptive immune response and is inhibited by IL-36 receptor antagonist (RA). IL-36RA acts on IL-36 receptor ligand which exerts proinflammatory effect in vivo and in vitro. IL-38 binds to IL-36 receptor as does IL-36RA and has similar biological effects on immune cells. IL-38 is also a member of IL-1 cytokine and shares some characteristics of IL-1RA, binding the same IL-1 receptor type I. IL-38 plays a role in the pathogenesis of inflammatory diseases, exerting protective effect in some autoimmune diseases. Both IL-38 and IL-36RA have an anti-inflammatory biological effect, however in some cases have contrary effects.


Subject(s)
Interleukins/immunology , Receptors, Interleukin/antagonists & inhibitors , Animals , Anti-Inflammatory Agents/pharmacology , Humans , Receptors, Interleukin/immunology
2.
J Biol Regul Homeost Agents ; 23(4): 231-8, 2009.
Article in English | MEDLINE | ID: mdl-20003762

ABSTRACT

Mast cells play a role in various physiological functions: innate and acquired immunity, epithelium remodelling and proliferation, angiogenesis, cancer, inflammation and infections. Mast cells are activated by cross-linking of FcERI molecules, which are involved in the binding of multivalent antigens to the attached IgE molecules, resulting in a variety of responses including the immediate release of potent inflammatory mediators. In addition, mast cell biology consists in the capability to secrete preformed mediators which include biogenic amines and newly synthetized mediators, which include lipid-derived mediators and cytokines. It has been reported that parasite infections induce a systemic immunomodulatory network, including regulatory T cells, pro-inflammatory and anti-inflammatory cytokines, which might play a key role in the allergic phenotype. Here, in this article, we revisited the relationship between mast cells and infections.


Subject(s)
Immunoglobulin E/immunology , Infections/immunology , Inflammation Mediators/immunology , Mast Cells/immunology , Receptors, IgE/immunology , Animals , Humans , Immunoglobulin E/metabolism , Infections/metabolism , Infections/parasitology , Inflammation Mediators/metabolism , Mast Cells/metabolism , Receptors, IgE/metabolism
3.
J Biol Regul Homeost Agents ; 23(3): 141-7, 2009.
Article in English | MEDLINE | ID: mdl-19828090

ABSTRACT

IL-32, a newly-discovered proinflammatory cytokine that activates the p38MAPK and NF-kappaB pathways, is an important player in innate and adaptive immune response. IL-32, a cytokine produced mainly by T, natural killer, and epithelial cells induces significant amounts of TNFalpha and MIP-2 and increases the production of both cytokines in a dose-dependent manner. IL-32 has been implicated in inflammatory disorders, mycobacterium tuberculosis infections, inflammatory bowel disease, and influenza A virus infection, as well as in some autoimmune diseases, such as rheumatoid arthritis, ulcerative colitis and Crohn?s disease and in human stomach cancer, human lung cancer and breast cancer tissues. Moreover, it has been reported that IL-32 has pro-inflammatory effects on myeloid cells and causes the differentiation of osteoclast precursors into multinucleated cells expressing specific osteoclast markers. We recently found that human IL-32 has the capacity to provoke histamine release in human-derived cord blood mast cells (HDCBMC), but not in LAD 2 cells nor in rat peritoneal mast cells (RPMC), showing that IL-32 may be specie specific and act more in mature human mast cells (HDCBMC) than in transformed mast cells (LAD 2 cells). Certainly, IL-32 is another potent proinflammatory cytokine, however, the specific role of this newly-discovered protein in the network of cytokine biology remains to be determined.


Subject(s)
Inflammation Mediators/metabolism , Interleukins/metabolism , Animals , Cell Differentiation , Humans , Immunity , NF-kappa B/metabolism
4.
J Biol Regul Homeost Agents ; 23(2): 65-9, 2009.
Article in English | MEDLINE | ID: mdl-19589286

ABSTRACT

Chlamydia pneumoniae (C. pneumoniae), a respiratory pathogen, has been implicated in the pathogenesis of atherosclerosis, an inflammatory progressive disease, characterized by the formation of atherosclerotic plaques. Among several types of inflammatory cells involved in the atherogenesis process, recently particular attention has been directed toward the mast cells. Experimental studies have provided several mechanisms by which C. pneumoniae and mast cells could play a role in all stages of atherosclerosis, from initial inflammatory lesions to plaque rupture. C. pneumoniae, as well as mast cells, may actively participate both through the production of cytokines and matrix-degrading metalloproteinases and by provoking apoptosis of atheroma-associated vascular cells, key events in plaque rupture. This mini-review provides a brief overview on adventitial inflammatory effects of C. pneumoniae and mast cells and their potential role in plaque instability. In addition, in this paper we review the role of mast cells in innate immunity.


Subject(s)
Atherosclerosis/etiology , Chlamydia Infections/complications , Chlamydophila pneumoniae/pathogenicity , Mast Cells/pathology , Atherosclerosis/immunology , Atherosclerosis/microbiology , Atherosclerosis/pathology , Chlamydia Infections/immunology , Chlamydia Infections/pathology , Humans , Immunity, Innate , Inflammation/complications , Inflammation/immunology , Inflammation/pathology , Mast Cells/immunology
5.
Int J Immunopathol Pharmacol ; 22(1): 15-9, 2009.
Article in English | MEDLINE | ID: mdl-19309548

ABSTRACT

Autism spectrum disorder is of interest neurochemically because it represents a relatively homogeneous disorder with regard to disease development, abnormal cognitive development and intellectual development disturbance. A consistent finding in autistic children is a high number of mast cells and a high level of serotonin which is also found at elevated concentrations in the urine of autistic patients. In addition, a dysfunction of clinical conditions, such as gastrointestinal and immunological symptoms, is frequently noted in autistic children, however, IgE does not appear to be prevalent in these children but probably an increase of cytokines/chemokines produced by mast cells at an early age may play an important role. Therefore an immune hypothesis, involving also autoimmunity, is one possible pathogenetic mechanism in autism. In conclusion, mast cell activation could contribute to immune and neuroinflammatory abnormalities that are evident in patients with autism spectrum disorders.


Subject(s)
Autistic Disorder/immunology , Immunity , Ammonia/blood , Cytokines/biosynthesis , Humans , Mast Cells/physiology , Serotonin/physiology
6.
J Biol Regul Homeost Agents ; 23(1): 11-4, 2009.
Article in English | MEDLINE | ID: mdl-19321041

ABSTRACT

IL-33, a member of IL-1 family, induces the differentiation of T-cells (depending on the phosphorylation of MAPKs and NF-kB) and is involved in T-cell mediated immune responses. IL-33 is also involved in the production of IL-5, IL-4 and IL-13 and several chemokines. In this editorial we show the importance of IL-33 in allergic diseases and its role as an inflammatory cytokine. In addition, the induction of certain chemokines by IL-33 may candidate this new cytokine as a mediator in inflammatory and autoimmune diseases and may prove to be a therapeutic target for the prevention of these diseases.


Subject(s)
Interleukin-1/immunology , Interleukins/immunology , Mast Cells/immunology , Animals , Asthma/immunology , Atherosclerosis/immunology , Mice
7.
Int J Immunopathol Pharmacol ; 21(2): 255-9, 2008.
Article in English | MEDLINE | ID: mdl-18547468

ABSTRACT

The tridecapeptide neurotensin (NT) acts in the mammalian brain as a primary neurotransmitter or neuromodulator of classical neurotransmitters. Morphological and functional in vitro and in vivo studies have demonstrated the existence of close interactions between NT and dopamine both in limbic and in striatal brain regions. Additionally, biochemical and neurochemical evidence indicates that in these brain regions NT also plays a crucial role in the regulation of the aminoacidergic signalling. Immune cells, such as lymphocytes, macrophages and mast cells are reported to be activated by neuropeptides, such as neurotensin; this activation leads to cytokine and immunoglobulin production. In addition, neurotensin increases calcium level and the production of nitric oxide. Therefore neurotensin is deeply involved in immunity and inflammation but its real function still remains to be elucidated.


Subject(s)
Neurotensin/physiology , Neurotransmitter Agents/physiology , Animals , Behavior/physiology , Brain Chemistry , Gastrointestinal Tract/physiology , Humans , Neurotensin/immunology , Neurotensin/metabolism , Neurotransmitter Agents/metabolism , Tissue Distribution
8.
Int J Biol Markers ; 22(3): 226-31, 2007.
Article in English | MEDLINE | ID: mdl-17922468

ABSTRACT

Inducible nitric oxide synthase (iNOS) is one of three enzymes generating nitric oxide (NO) from the amino acid L-arginine. iNOS-derived NO plays an important role in several physiological and pathophysiological conditions. NO is a free radical which produces many reactive intermediates that account for its bioactivity. In the human lung, the alveolar macrophage is an important producer of cytokines and this production may be modified by NO. Moreover, high concentrations of NO have been shown to increase nuclear factor kappaB (NF-kB) activation. Recent investigations of NO expression in tumor tissue indicated that, at least for certain tumors, NO may mediate one or more roles during the growth of human cancer. We have studied iNOS in two tissue groups: normal human lung tissue and human lung cancer tissue. We localized iNOS in these tissues by immunohistochemistry and tested the mRNA expression by RT-PCR, the protein level by Western blot, and the protein activity by radiometric analysis. The results demonstrate different expression, localization and activity of iNOS in normal versus tumor tissue. This is suggestive of a role for NO production from iNOS in human lung cancer because high concentrations of this short molecule may transform to highly reactive compounds such as peroxynitrite (ONOO-); moreover, through the upregulator NF-kB, they can induce a chronic inflammatory state representing an elevated risk for cell transformation to cancer.


Subject(s)
Biomarkers, Tumor/metabolism , Lung Neoplasms/enzymology , Lung/enzymology , Nitric Oxide Synthase Type II/metabolism , Apoptosis/physiology , Blotting, Western , Cytokines/biosynthesis , Humans , Immunohistochemistry , Lung/cytology , Lung Neoplasms/pathology , NF-kappa B/biosynthesis , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide Synthase Type II/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction
10.
Int J Biol Markers ; 22(4): 312, 2007.
Article in English | MEDLINE | ID: mdl-28207121

ABSTRACT

Errata Corrige. In the article 'Localization and activity of iNOS in normal human lung tissue and lung cancer tissue' by Speranza L et al, which was published in the July-September issue of the International Journal of Biological Markers (Int J Biol Markers 2007; 22 (3): 226-231), the name of the 6th Author was misprinted. We reprint here with his correct name: S. Tet.

11.
J Biol Regul Homeost Agents ; 20(3-4): 47-52, 2006.
Article in English | MEDLINE | ID: mdl-18187018

ABSTRACT

An investigated flavonoid, quercetin, is reviewed in this article. Quercetin is a bioflavonoid found in red wine, grapefruit, onions, apples, black tea, and, in lesser amounts, in leafy green vegetables and beans. Quercetin has an antioxidant and anti-inflammatory activity and prevents cancer. Quercitin inhibits the growth of certain malignant cells in vitro, and histamine and most cyclin-dependent kinases and also displays unique anticancer properties. Quercetin is a natural compound that blocks substances involved in allergies and is able to act as an inhibitor of mast cell secretion, causes a decrease in the release of tryptase, MCP-1 and IL-6 and the down-regulation of histidine decarboxylase (HDC) mRNA from few mast cell lines. Quercetin is a safe, natural therapy that may be used as primary therapy or in conjunction with conventional methods.


Subject(s)
Quercetin , Tryptases , Humans , Hypersensitivity/metabolism , Inflammation/metabolism , Mast Cells/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...